Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Viral Vector Vaccines industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Pfizer
CureVac
Serum Institute of India Pvt Ltd
Moderna Therapeutics
FHoffman La Roche Ltd
GlaxoSmithKline Plc
BioNTech
Sanofi Pasteur Inc (Sanofi S/A)
AstraZeneca
Novartis
Sinnovac Biotech Ltd
By Type:
Others
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
By Application:
Hospitals
Clinics
Others
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Viral Vector Vaccines Market Overview 2018-2029
-
1.1 China Viral Vector Vaccines Industry Development Overview
-
1.2 China Viral Vector Vaccines Industry Development History
-
1.3 China Viral Vector Vaccines Industry Market Size (2018-2029)
-
1.4 China Viral Vector Vaccines Market Analysis by Type from Production Side
-
1.4.1 China Viral Vector Vaccines Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.2 China Viral Vector Vaccines Production Volume, Production Value and Growth Rate of Adenovirus (2018-2029)
-
1.4.3 China Viral Vector Vaccines Production Volume, Production Value and Growth Rate of Fowlpox Virus (2018-2029)
-
1.4.4 China Viral Vector Vaccines Production Volume, Production Value and Growth Rate of Attenuated Yellow Fever (2018-2029)
-
1.4.5 China Viral Vector Vaccines Production Volume, Production Value and Growth Rate of Vaccinia Virus Vectors (2018-2029)
-
1.5 China Viral Vector Vaccines Market Analysis by Application from Consumption End
-
1.5.1 China Viral Vector Vaccines Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.2 China Viral Vector Vaccines Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
1.5.3 China Viral Vector Vaccines Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.6 China Viral Vector Vaccines Market Analysis by Region
-
1.6.1 North China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
Chapter 2 China Viral Vector Vaccines Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Viral Vector Vaccines Market Status and Competition at home and abroad in 2023
-
2.2.2 China Viral Vector Vaccines Market Status and Competition Analysis in 2023
-
2.2.3 China Viral Vector Vaccines Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Viral Vector Vaccines Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Viral Vector Vaccines Industry Development
Chapter 3 Viral Vector VaccinesIndustry Chain Analysis
-
3.1 Viral Vector Vaccines Industry Chain
-
3.2 Viral Vector Vaccines Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Viral Vector Vaccines Market
-
3.3 Viral Vector Vaccines Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Viral Vector Vaccines Market
Chapter 4 China Viral Vector Vaccines Market, by Type
-
4.1 China Viral Vector Vaccines Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Viral Vector Vaccines Total Production Volume and Growth Rate from Production Side
-
4.5 China Viral Vector Vaccines Production Volume and Growth Rate, by Type
-
4.5.1 China Viral Vector Vaccines Production Volume and Growth Rate of Others
-
4.5.2 China Viral Vector Vaccines Production Volume and Growth Rate of Adenovirus
-
4.5.3 China Viral Vector Vaccines Production Volume and Growth Rate of Fowlpox Virus
-
4.5.4 China Viral Vector Vaccines Production Volume and Growth Rate of Attenuated Yellow Fever
-
4.5.5 China Viral Vector Vaccines Production Volume and Growth Rate of Vaccinia Virus Vectors
Chapter 5 China Viral Vector Vaccines Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Viral Vector Vaccines Total Market Size and Growth Rate from Consumption End
-
5.5 China Viral Vector Vaccines Market Size and Growth Rate, by Application
-
5.5.1 China Viral Vector Vaccines Market Size and Growth Rate of Hospitals
-
5.5.2 China Viral Vector Vaccines Market Size and Growth Rate of Clinics
-
5.5.3 China Viral Vector Vaccines Market Size and Growth Rate of Others
Chapter 6 China Viral Vector Vaccines Market, by Region
-
6.1 China Viral Vector Vaccines Production Volume and Production Value, by Region
-
6.2 China Viral Vector Vaccines Sales Volume and Sales Value, by Region
Chapter 7 North China Viral Vector Vaccines Market Analysis
-
7.1 North China Viral Vector Vaccines Market, by Type
-
7.2 North China Viral Vector Vaccines Market, by Application
Chapter 8 Central China Viral Vector Vaccines Market Analysis
-
8.1 Central China Viral Vector Vaccines Market, by Type
-
8.2 Central China Viral Vector Vaccines Market, by Application
Chapter 9 South China Viral Vector Vaccines Market Analysis
-
9.1 South China Viral Vector Vaccines Market, by Type
-
9.2 South China Viral Vector Vaccines Market, by Application
Chapter 10 East China Viral Vector Vaccines Market Analysis
-
10.1 East China Viral Vector Vaccines Market, by Type
-
10.2 East China Viral Vector Vaccines Market, by Application
Chapter 11 Northeast China Viral Vector Vaccines Market Analysis
-
11.1 Northeast China Viral Vector Vaccines Market, by Type
-
11.2 Northeast China Viral Vector Vaccines Market, by Application
Chapter 12 Southwest China Viral Vector Vaccines Market Analysis
-
12.1 Southwest China Viral Vector Vaccines Market, by Type
-
12.2 Southwest China Viral Vector Vaccines Market, by Application
Chapter 13 Northwest China Viral Vector Vaccines Market Analysis
-
13.1 Northwest China Viral Vector Vaccines Market, by Type
-
13.2 Northwest China Viral Vector Vaccines Market, by Application
Chapter 14 Company Profiles
-
14.1 Pfizer
-
14.1.1 Pfizer Company Profile
-
14.1.2 Pfizer Viral Vector Vaccines Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 CureVac
-
14.2.1 CureVac Company Profile
-
14.2.2 CureVac Viral Vector Vaccines Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Serum Institute of India Pvt Ltd
-
14.3.1 Serum Institute of India Pvt Ltd Company Profile
-
14.3.2 Serum Institute of India Pvt Ltd Viral Vector Vaccines Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Moderna Therapeutics
-
14.4.1 Moderna Therapeutics Company Profile
-
14.4.2 Moderna Therapeutics Viral Vector Vaccines Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 FHoffman La Roche Ltd
-
14.5.1 FHoffman La Roche Ltd Company Profile
-
14.5.2 FHoffman La Roche Ltd Viral Vector Vaccines Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 GlaxoSmithKline Plc
-
14.6.1 GlaxoSmithKline Plc Company Profile
-
14.6.2 GlaxoSmithKline Plc Viral Vector Vaccines Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 BioNTech
-
14.7.1 BioNTech Company Profile
-
14.7.2 BioNTech Viral Vector Vaccines Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Sanofi Pasteur Inc (Sanofi S/A)
-
14.8.1 Sanofi Pasteur Inc (Sanofi S/A) Company Profile
-
14.8.2 Sanofi Pasteur Inc (Sanofi S/A) Viral Vector Vaccines Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 AstraZeneca
-
14.9.1 AstraZeneca Company Profile
-
14.9.2 AstraZeneca Viral Vector Vaccines Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Novartis
-
14.10.1 Novartis Company Profile
-
14.10.2 Novartis Viral Vector Vaccines Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Sinnovac Biotech Ltd
-
14.11.1 Sinnovac Biotech Ltd Company Profile
-
14.11.2 Sinnovac Biotech Ltd Viral Vector Vaccines Market Performance
-
14.11.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Viral Vector Vaccines Industry Research Conclusions
-
15.2 Viral Vector Vaccines Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Viral Vector Vaccines Industry Market Size (2018-2029)
-
Figure China Viral Vector Vaccines Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Viral Vector Vaccines Production Volume, Production Value and Growth Rate of Adenovirus (2018-2029)
-
Figure China Viral Vector Vaccines Production Volume, Production Value and Growth Rate of Fowlpox Virus (2018-2029)
-
Figure China Viral Vector Vaccines Production Volume, Production Value and Growth Rate of Attenuated Yellow Fever (2018-2029)
-
Figure China Viral Vector Vaccines Production Volume, Production Value and Growth Rate of Vaccinia Virus Vectors (2018-2029)
-
Figure China Viral Vector Vaccines Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China Viral Vector Vaccines Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
Figure China Viral Vector Vaccines Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure North China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Central China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
Figure South China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
Figure East China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Viral Vector Vaccines Market Size and Growth Rate from 2018-2029
-
Figure Viral Vector Vaccines Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Viral Vector Vaccines Market Share by Type in 2018
-
Figure China Viral Vector Vaccines Market Share by Type in 2023
-
Figure China Viral Vector Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Viral Vector Vaccines Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Viral Vector Vaccines Production Volume and Growth Rate of Adenovirus (2018-2023)
-
Figure China Viral Vector Vaccines Production Volume and Growth Rate of Fowlpox Virus (2018-2023)
-
Figure China Viral Vector Vaccines Production Volume and Growth Rate of Attenuated Yellow Fever (2018-2023)
-
Figure China Viral Vector Vaccines Production Volume and Growth Rate of Vaccinia Virus Vectors (2018-2023)
-
Figure China Viral Vector Vaccines Market Share by Application in 2018
-
Figure China Viral Vector Vaccines Market Share by Application in 2023
-
Figure China Viral Vector Vaccines Total Market Size and Growth Rate from Consumption End
-
Figure China Viral Vector Vaccines Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China Viral Vector Vaccines Market Size and Growth Rate of Clinics (2018-2023)
-
Figure China Viral Vector Vaccines Market Size and Growth Rate of Others (2018-2023)
-
Table China Viral Vector Vaccines Production Volume by Region (2018-2023)
-
Table China Viral Vector Vaccines Production Volume Share by Region (2018-2023)
-
Figure China Viral Vector Vaccines Production Volume Share by Region (2018-2023)
-
Table China Viral Vector Vaccines Production Value by Region (2018-2023)
-
Table China Viral Vector Vaccines Production Value Share by Region (2018-2023)
-
Figure China Viral Vector Vaccines Production Value Share by Region (2018-2023)
-
Table China Viral Vector Vaccines Sales Volume by Region (2018-2023)
-
Table China Viral Vector Vaccines Sales Volume Share by Region (2018-2023)
-
Figure China Viral Vector Vaccines Sales Volume Share by Region (2018-2023)
-
Table China Viral Vector Vaccines Sales Value by Region (2018-2023)
-
Table China Viral Vector Vaccines Sales Value Share by Region (2018-2023)
-
Figure China Viral Vector Vaccines Sales Value Share by Region (2018-2023)
-
Table North China Viral Vector Vaccines Production Volume by Type (2018-2023)
-
Table North China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Figure North China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Table North China Viral Vector Vaccines Sales Volume by Application (2018-2023)
-
Table North China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Figure North China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Table Central China Viral Vector Vaccines Production Volume by Type (2018-2023)
-
Table Central China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Figure Central China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Table Central China Viral Vector Vaccines Sales Volume by Application (2018-2023)
-
Table Central China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Figure Central China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Table South China Viral Vector Vaccines Production Volume by Type (2018-2023)
-
Table South China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Figure South China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Table South China Viral Vector Vaccines Sales Volume by Application (2018-2023)
-
Table South China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Figure South China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Table East China Viral Vector Vaccines Production Volume by Type (2018-2023)
-
Table East China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Figure East China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Table East China Viral Vector Vaccines Sales Volume by Application (2018-2023)
-
Table East China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Figure East China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Table Northeast China Viral Vector Vaccines Production Volume by Type (2018-2023)
-
Table Northeast China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Figure Northeast China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Table Northeast China Viral Vector Vaccines Sales Volume by Application (2018-2023)
-
Table Northeast China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Table Southwest China Viral Vector Vaccines Production Volume by Type (2018-2023)
-
Table Southwest China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Figure Southwest China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Table Southwest China Viral Vector Vaccines Sales Volume by Application (2018-2023)
-
Table Southwest China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Table Northwest China Viral Vector Vaccines Production Volume by Type (2018-2023)
-
Table Northwest China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Figure Northwest China Viral Vector Vaccines Production Volume Share by Type (2018-2023)
-
Table Northwest China Viral Vector Vaccines Sales Volume by Application (2018-2023)
-
Table Northwest China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Viral Vector Vaccines Sales Volume Share by Application (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Viral Vector Vaccines Revenue, Price and Gross (2018-2023)
-
Table CureVac Company Profile
-
Table CureVac Viral Vector Vaccines Revenue, Price and Gross (2018-2023)
-
Table Serum Institute of India Pvt Ltd Company Profile
-
Table Serum Institute of India Pvt Ltd Viral Vector Vaccines Revenue, Price and Gross (2018-2023)
-
Table Moderna Therapeutics Company Profile
-
Table Moderna Therapeutics Viral Vector Vaccines Revenue, Price and Gross (2018-2023)
-
Table FHoffman La Roche Ltd Company Profile
-
Table FHoffman La Roche Ltd Viral Vector Vaccines Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Plc Company Profile
-
Table GlaxoSmithKline Plc Viral Vector Vaccines Revenue, Price and Gross (2018-2023)
-
Table BioNTech Company Profile
-
Table BioNTech Viral Vector Vaccines Revenue, Price and Gross (2018-2023)
-
Table Sanofi Pasteur Inc (Sanofi S/A) Company Profile
-
Table Sanofi Pasteur Inc (Sanofi S/A) Viral Vector Vaccines Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Viral Vector Vaccines Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Viral Vector Vaccines Revenue, Price and Gross (2018-2023)
-
Table Sinnovac Biotech Ltd Company Profile
-
Table Sinnovac Biotech Ltd Viral Vector Vaccines Revenue, Price and Gross (2018-2023)
-
